Company profile for AceLink Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

AceLink Therapeutics is a clinical-stage drug development company that leverages deep understanding of glycolipid biology to develop groundbreaking therapies for genetic diseases and kidney diseases. AceLink consists of a seasoned team of drug development professionals, consultants, and advisors with a rich knowledge of glycolipid biology, kidney disease, and drug development. We collaborate with an experienced network of ...
AceLink Therapeutics is a clinical-stage drug development company that leverages deep understanding of glycolipid biology to develop groundbreaking therapies for genetic diseases and kidney diseases. AceLink consists of a seasoned team of drug development professionals, consultants, and advisors with a rich knowledge of glycolipid biology, kidney disease, and drug development. We collaborate with an experienced network of contract research organizations, academics, and key opinion leaders (KOLs). This model allows us to efficiently transform scientific discoveries into impactful new therapies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
39600 Eureka Drive, Suite 151, Newark, CA 94560
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Clinical Outsourcing

Clinical Outsourcing

Not Confirmed

envelop Contact Supplier

Clinical Outsourcing

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us
read-more

https://www.businesswire.com/news/home/20250814528346/en/AceLink-Therapeutics-Completes-6-Month-Primary-Phase-of-AL01211-Clinical-Study-in-Fabry-Disease-Patients

BUSINESSWIRE
14 Aug 2025

https://www.businesswire.com/news/home/20250207924380/en

BUSINESSWIRE
07 Feb 2025

https://www.businesswire.com/news/home/20240226569957/en

BUSINESSWIRE
26 Feb 2024

https://www.businesswire.com/news/home/20231031050670/en

BUSINESSWIRE
31 Oct 2023

https://www.businesswire.com/news/home/20230810290371/en

BUSINESSWIRE
10 Aug 2023

https://www.clinicaltrialsarena.com/news/acelink-therapeutics-fabry-disease/

CLINICAL TRIALS ARENA
22 Jun 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty